Perez-Elias, Maria J.

Publishing since 1996 (Senior)

Has published 59 publications in 15 years

Number of publications published per year by Perez-Elias, Maria J.. (Source : PubMed)

Distribution of publications types for Perez-Elias, Maria J.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Poveda E, Anta L, Blanco JL, Pérez-Elías MJ, García F, Leal M, Ribera E, Gutiérrez F, Soriano V, de Mendoza C. Etravirine resistance associated mutations in HIV-infected patients failing efavirenz or nevirapine in the Spanish antiretroviral resistance database.  AIDS  2010;24;3  
•  Moreno A, Pérez-Elías MJ, Casado JL, Fortún J, Bárcena R, Quereda C, Del Campo S, Gutiérrez C, Pastor O, Nuño J, Fernandez A, Moreno S. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.  Liver Transpl.  2009  
•  Pérez-Elías MJ, Moreno A, Casado JL, Dronda F, Antela A, López D, Quereda C, Navas E, Hermida JM, Del Sol E, Moreno S. Observational study to evaluate clinical outcomes after first-line efavirenz-or lopinavir-ritonavir-based HAART in treatment-naive patients.  J Int Assoc Physicians AIDS Care (Chic Ill)  2009;8;5  
•  Pérez-Elías MJ, Gatell JM, Flores J, Santos J, Vera-Médez F, Clotet B, Moreno A, Pérez-Molina JA, Vendrell B, Serrano O. Short-term effect of ritonavir-boosted atazanavir in hepatitis B and/or C co-infected, treatment-experienced HIV patients.  HIV Clin Trials  2009;10;4  
•  Pérez-Molina JA, López-Vélez R, Navarro M, Pérez-Elías MJ, Moreno S. Clinicoepidemiological characteristics of HIV-infected immigrants attended at a tropical medicine referral unit.  J Travel Med  2009;16;4  
•  Arribas JR, Delgado R, Arranz A, Muñoz R, Portilla J, Pasquau J, Pérez-Elias MJ, Iribarren JA, Rubio R, Ocampo A, Sánchez-Conde M, Knobel H, Arazo P, Sanz J, López-Aldeguer J, Montes ML, Pulido F. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis.  J. Acquir. Immune Defic. Syndr.  2009;51;2  
•  Pérez-Elías MJ, García-San Miguel L, González García J, Montes Ramírez ML, Muriel A, Machín-Lázaro JM, Martínez-Baltanás A, Zamora F, Moreno A, Martín-Dávila P, Quereda C, Gómez-Mampaso E, Moreno S. Tuberculosis complicating hepatitis C treatment in HIV-infected patients.  Clin. Infect. Dis.  2009;48;8  
•  de Mendoza C, Anta L, García F, Pérez-Elías MJ, Gutiérrez F, Llibre JM, Menéndez-Arias L, Dalmau D, Soriano V. HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.  AIDS Rev  2009;11;1  
•  Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, Rubio R, González-García J, Miralles P, Pérez-Elías MJ, Ocampo A, Hernando A, Estrada V, Clotet B, Podzamczer D, Arribas JR. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.  Antivir. Ther. (Lond.)  2009;14;2  
•  Moreno A, Bárcena R, García-Gonzalez M, García-Hoz F, Quereda C, Casado JL, Pérez-Elías MJ, Fortún J, Nuño J, Arranz I, Moreno S. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.  Transplant. Proc.  2008;40;10  

[ See timeline ] [ See all publications ]